Navidea Biopharmaceuticals, Inc. Announces Executive Changes
On March 16, 2023 the Company's Board of Directors (the Board) designated Joseph W. Meyer as the Company's Principal Financial Officer and Principal Accounting Officer, effective upon Ms. Eves' departure from the Company. Mr. Meyer, age 35, has served as Controller of the Company since April 2022. Mr. Meyer also served as the Company's Accounting Manager from March 2017 to March 2022. Mr. Meyer holds a B.B.A. from Ohio University College of Business.